Aortic Aneurysm Market Players:
- Medtronic
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- W. L. Gore & Associates, Inc.
- MicroPort Scientific Corporation
- Terumo Corporation
- Endologix LLC
- Boston Scientific Corporation
- Japan Lifeline Co., Ltd.
- Bentley InnoMed GmbH
The current dynamics of the aortic aneurysm market are following the trend of innovation and globalization. To participate in this cohort, key players in this field are increasingly expanding their territory in un-tapped or emerging landscapes. For instance, in May 2023, Therapeutic Solutions International formed a new subsidiary, VasoSome Vascular Inc., cultivating innovative AA treatments by utilizing stem cell–derived exosomes. Simultaneously, in August 2024, Terumo introduced its advanced solution for EVAR procedures, TREO Stent-Graft System, to the market in India. This remarkable device is capable of supporting both suprarenal and infrarenal active fixation, solidifying the company’s debut overseas. Such key players are:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of aortic aneurysm is evaluated at USD 6.27 billion.
The global aortic aneurysm market size was worth over USD 5.71 billion in 2025 and is poised to grow at a CAGR of more than 10.9%, reaching USD 16.07 billion revenue by 2035.
The North America aortic aneurysm market is projected to capture a 40% share by 2035, driven by top-tier healthcare and R&D on innovative AA treatments.
Key players in the market include Medtronic, W. L. Gore & Associates, Inc., MicroPort Scientific Corporation, Terumo Corporation, Endologix LLC, Boston Scientific Corporation, Japan Lifeline Co., Ltd.
